miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics

References

• Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al., Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 2007; 21(21): p. 2683-710; PMID:17974913; http://dx.doi.org/10.1101/gad.1596707
   PubMed Web of Science ®Google Scholar
• Kouri FM, Hurley LA, Daniel WL, Day ES, Hua Y, Hao L, Peng CY, Merkel TJ, Queisser MA, Ritner C, et al., miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma. Genes Dev 2015; 29(7): p. 732-45; PMID:25838542; http://dx.doi.org/10.1101/gad.257394.114
   PubMed Web of Science ®Google Scholar
• Jensen SA, Day ES, Ko CH, Hurley LA, Luciano JP, Kouri FM, Merkel TJ, Luthi AJ, Patel PC, Cutler JI, et al., Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma. Sci Transl Med 2013; 5(209): p. 209ra152; PMID:24174328; http://dx.doi.org/10.1126/scitranslmed.3006839
   PubMed Web of Science ®Google Scholar
• Mirkin CA, Stegh AH. Spherical nucleic acids for precision medicine. Oncotarget 2014; 5(1): p. 9-10; PMID:24398537; http://dx.doi.org/10.18632/oncotarget.1757
   PubMed Web of Science ®Google Scholar
• Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009; 11(3): p. 228-34; PMID:19255566; http://dx.doi.org/10.1038/ncb0309-228
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116(2): p. 281-97; PMID:14744438; http://dx.doi.org/10.1016/S0092-8674(04)00045-5
   PubMed Web of Science ®Google Scholar
• Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011 12(12): p. 861-74; PMID:22094949; http://dx.doi.org/10.1038/nrg3074
   PubMed Web of Science ®Google Scholar
• Coolen M, Bally-Cuif L. MicroRNAs in brain development and physiology. Curr Opin Neurobiol 2009; 19(5): p. 461-70; PMID:19846291; http://dx.doi.org/10.1016/j.conb.2009.09.006
   PubMed Web of Science ®Google Scholar
• Wang W, Kwon EJ, Tsai LH. MicroRNAs in learning, memory, and neurological diseases. Learn Mem 2012 19(9): p. 359-68; PMID:22904366; http://dx.doi.org/10.1101/lm.026492.112
   PubMed Web of Science ®Google Scholar
• Schaefer A, O'Carroll D, Tan CL, Hillman D, Sugimori M, Llinas R, Greengard P. Cerebellar neurodegeneration in the absence of microRNAs. J Exp Med 2007; 204(7): p. 1553-8; PMID:17606634; http://dx.doi.org/10.1084/jem.20070823
   PubMed Web of Science ®Google Scholar
• Krichevsky AM, Sonntag KC, Isacson O, Kosik KS. Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 2006; 24(4): p. 857-64; PMID:16357340; http://dx.doi.org/10.1634/stemcells.2005-0441
   PubMed Web of Science ®Google Scholar
• Conaco C, Otto S, Han JJ, Mandel G. Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Natl Acad Sci U S A 2006; 103(7): p. 2422-7; PMID:16461918; http://dx.doi.org/10.1073/pnas.0511041103
   PubMed Web of Science ®Google Scholar
• Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL. The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J Neurosci 2008; 28(53): p. 14341-6; PMID:19118166; http://dx.doi.org/10.1523/JNEUROSCI.2390-08.2008
   PubMed Web of Science ®Google Scholar
• Makeyev EV, Zhang J, Carrasco MA, Maniatis T. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell 2007; 27(3): p. 435-48; PMID:17679093; http://dx.doi.org/10.1016/j.molcel.2007.07.015
   PubMed Web of Science ®Google Scholar
• Cheng LC, Pastrana E, Tavazoie M, Doetsch F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci 2009; 12(4): p. 399-408; PMID:19287386; http://dx.doi.org/10.1038/nn.2294
   PubMed Web of Science ®Google Scholar
• Meng Y, Zhang Y, Tregoubov V, Janus C, Cruz L, Jackson M, Lu WY, MacDonald JF, Wang JY, Falls DL, et al., Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice. Neuron 2002; 35(1): p. 121-33; PMID:12123613; http://dx.doi.org/10.1016/S0896-6273(02)00758-4
   PubMed Web of Science ®Google Scholar
• Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M, Greenberg ME. A brain-specific microRNA regulates dendritic spine development. Nature 2006; 439(7074): p. 283-9; PMID:16421561; http://dx.doi.org/10.1038/nature04367
   PubMed Web of Science ®Google Scholar
• Siegel G, Obernosterer G, Fiore R, Oehmen M, Bicker S, Christensen M, Khudayberdiev S, Leuschner PF, Busch CJ, Kane C, et al., A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat Cell Biol 2009; 11(6): p. 705-16; PMID:19465924; http://dx.doi.org/10.1038/ncb1876
   PubMed Web of Science ®Google Scholar
• Le MT, Teh C, Shyh-Chang N, Xie H, Zhou B, Korzh V, Lodish HF, Lim B. MicroRNA-125b is a novel negative regulator of p53. Genes Dev 2009; 23(7): p. 862-76; PMID:19293287; http://dx.doi.org/10.1101/gad.1767609
   PubMed Web of Science ®Google Scholar
• Walker JC, Harl RM. microRNA-24a is required to repress apoptosis in the developing neural retina. Genes Dev 2009; 23(9): p. 1046-51; PMID:19372388; http://dx.doi.org/10.1101/gad.1777709
   PubMed Web of Science ®Google Scholar
• Silber J, James CD, Hodgson JG. microRNAs in gliomas: small regulators of a big problem. Neuromolecular Med 2009; 11(3): p. 208-22; PMID:19731102; http://dx.doi.org/10.1007/s12017-009-8087-9
   PubMed Web of Science ®Google Scholar
• Nagane M, Levitzki A, Gazit A, Cavenee WK, Huang HJ. Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases. Proc Natl Acad Sci U S A 1998; 95(10): p. 5724-9; PMID:9576951; http://dx.doi.org/10.1073/pnas.95.10.5724
   PubMed Web of Science ®Google Scholar
• Stiles CD, Rowitch DH. Glioma stem cells: a midterm exam. Neuron 2008; 58(6): p. 832-46; PMID:18579075; http://dx.doi.org/10.1016/j.neuron.2008.05.031
   PubMed Web of Science ®Google Scholar
• Gilbertson RJ, Rich JN. Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer 2007; 7(10): p. 733-6; PMID:17882276; http://dx.doi.org/10.1038/nrc2246
   PubMed Web of Science ®Google Scholar
• Kim TM, Huang W, Park R, Park PJ, Johnson MD. A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs. Cancer Res 2011; 71(9): p. 3387-99; PMID:21385897; http://dx.doi.org/10.1158/0008-5472.CAN-10-4117
   PubMed Web of Science ®Google Scholar
• Zhou X, Ren Y, Moore L, Mei M, You Y, Xu P, Wang B, Wang G, Jia Z, Pu P, et al., Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab Invest 2010; 90(2): p. 144-55; PMID:20048743; http://dx.doi.org/10.1038/labinvest.2009.126
   PubMed Web of Science ®Google Scholar
• Kwak HJ, Kim YJ, Chun KR, Woo YM, Park SJ, Jeong JA, Jo SH, Kim TH, Min HS, Chae JS, et al., Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene 2011; 30(21): p. 2433-42; PMID:21278789; http://dx.doi.org/10.1038/onc.2010.620
   PubMed Web of Science ®Google Scholar
• Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, Krichevsky AM. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 2008; 28(17): p. 5369-80; PMID:18591254; http://dx.doi.org/10.1128/MCB.00479-08
   PubMed Web of Science ®Google Scholar
• Zhou X, Zhang J, Jia Q, Ren Y, Wang Y, Shi L, Liu N, Wang G, Pu P, You Y, et al., Reduction of miR-21 induces glioma cell apoptosis via activating caspase 9 and 3. Oncol Rep 2010; 24(1): p. 195-201; PMID:20514462
   PubMed Web of Science ®Google Scholar
• Gabriely G, Teplyuk NM, Krichevsky AM, Context effect: microRNA-10b in cancer cell proliferation, spread and death. Autophagy 2011; 7(11): p. 1384-6; PMID:21795860; http://dx.doi.org/10.4161/auto.7.11.17371
   PubMed Web of Science ®Google Scholar
• Gabriely G, Yi M, Narayan RS, Niers JM, Wurdinger T, Imitola J, Ligon KL, Kesari S, Esau C, Stephens RM, et al., Human glioma growth is controlled by microRNA-10b. Cancer Res 2011; 71(10): p. 3563-72; PMID:21471404; http://dx.doi.org/10.1158/0008-5472.CAN-10-3568
   PubMed Web of Science ®Google Scholar
• Guessous F, Alvarado-Velez M, Marcinkiewicz L, Zhang Y, Kim J, Heister S, Kefas B, Godlewski J, Schiff D, Purow B , et al., Oncogenic effects of miR-10b in glioblastoma stem cells. J Neurooncol 2013; 112(2): p. 153-63; PMID:23307328; http://dx.doi.org/10.1007/s11060-013-1047-0
   PubMed Web of Science ®Google Scholar
• Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sage C, Agami R, Tuschl T, et al., The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 2009; 23(11): p. 1327-37; PMID:19487573; http://dx.doi.org/10.1101/gad.1777409
   PubMed Web of Science ®Google Scholar
• Kim H, Huang W, Jiang X, Pennicooke B, Park PJ, Johnson MD. Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship. Proc Natl Acad Sci U S A 2010; 107(5): p. 2183-8; PMID:20080666; http://dx.doi.org/10.1073/pnas.0909896107
   PubMed Web of Science ®Google Scholar
• Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, Johnson E, Marcinkiewicz L, Jiang J, Yang Y, Schmittgen TD, et al., MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res 2009; 69(19): p. 7569-76; PMID:19773441; http://dx.doi.org/10.1158/0008-5472.CAN-09-0529
   PubMed Web of Science ®Google Scholar
• Silber J, Jacobsen A, Ozawa T, Harinath G, Pedraza A, Sander C, Holland EC, Huse JT. miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis. PLoS One 2012; 7(3): p. e33844; PMID:22479456; http://dx.doi.org/10.1371/journal.pone.0033844
   PubMed Web of Science ®Google Scholar
• Genovese G, Ergun A, Shukla SA, Campos B, Hanna J, Ghosh P, Quayle SN, Rai K, Colla S, Ying H, et al., microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-beta signaling in glioblastoma. Cancer Discov 2012; 2(8): p. 736-49; PMID:22750848; http://dx.doi.org/10.1158/2159-8290.CD-12-0111
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research, N., Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008; 455(7216): p. 1061-8; PMID:18772890; http://dx.doi.org/10.1038/nature07385
   PubMed Web of Science ®Google Scholar
• Huang PH, Mukasa A, Bonavia R, Flynn RA, Brewer ZE, Cavenee WK, Furnari FB, White FM. Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma. Proc Natl Acad Sci U S A 2007; 104(31): p. 12867-72; PMID:17646646; http://dx.doi.org/10.1073/pnas.0705158104
   PubMed Web of Science ®Google Scholar
• Stommel JM, Kimmelman AC, Ying H, Nabioullin R, Ponugoti AH, Wiedemeyer R, Stegh AH, Bradner JE, Ligon KL, Brennan C, et al., Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science 2007; 318(5848): p. 287-90; PMID:17872411; http://dx.doi.org/10.1126/science.1142946
   PubMed Web of Science ®Google Scholar
• Boccaccio C, Comoglio PM. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer 2006; 6(8): p. 637-45; PMID:16862193; http://dx.doi.org/10.1038/nrc1912
   PubMed Web of Science ®Google Scholar
• Boccaccio C, Comoglio PM. The MET oncogene in glioblastoma stem cells: implications as a diagnostic marker and a therapeutic target. Cancer Res 2013; 73(11): p. 3193-9; PMID:23695554; http://dx.doi.org/10.1158/0008-5472.CAN-12-4039
   PubMed Web of Science ®Google Scholar
• Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S, Shi Q, Cao Y, Lathia J, McLendon RE, et al., Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 2009; 15(6): p. 501-13; PMID:19477429; http://dx.doi.org/10.1016/j.ccr.2009.03.018
   PubMed Web of Science ®Google Scholar
• Boccaccio C, Comoglio PM. The MET oncogene in glioblastoma stem cells: implications as a diagnostic marker and a therapeutic target. Cancer Res 2013; 73(11): p. 3193-9; PMID:23695554; http://dx.doi.org/10.1158/0008-5472.CAN-12-4039
   PubMed Web of Science ®Google Scholar
• Rodgers JT, King KY, Brett JO, Cromie MJ, Charville GW, Maguire KK, Brunson C, Mastey N, Liu L, Tsai CR, et al., mTORC1 controls the adaptive transition of quiescent stem cells from G0 to G(Alert). Nature 2014; 510(7505): p. 393-6; PMID:24870234
   PubMed Web of Science ®Google Scholar
• Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11(4): p. 441-50; PMID:17011485; http://dx.doi.org/10.1016/j.devcel.2006.09.009
   PubMed Web of Science ®Google Scholar
• Weston MD, Pierce ML, Jensen-Smith HC, Fritzsch B, Rocha-Sanchez S, Beisel KW, Soukup GA. MicroRNA-183 family expression in hair cell development and requirement of microRNAs for hair cell maintenance and survival. Dev Dyn 2011; 240(4): p. 808-19; PMID:21360794; http://dx.doi.org/10.1002/dvdy.22591
   PubMed Web of Science ®Google Scholar
• Qu Y, Li WC, Hellem MR, Rostad K, Popa M, McCormack E, Oyan AM, Kalland KH, Ke XS. MiR-182 and miR-203 induce mesenchymal to epithelial transition and self-sufficiency of growth signals via repressing SNAI2 in prostate cells. Int J Cancer 2013; 133(3): p. 544-55; PMID:23354685; http://dx.doi.org/10.1002/ijc.28056
   PubMed Web of Science ®Google Scholar
• Kiernan AE, Pelling AL, Leung KK, Tang AS, Bell DM, Tease C, Lovell-Badge R, Steel KP, Cheah KS. Sox2 is required for sensory organ development in the mammalian inner ear. Nature 2005; 434(7036): p. 1031-5; PMID:15846349; http://dx.doi.org/10.1038/nature03487
   PubMed Web of Science ®Google Scholar
• Brooker R, Hozumi K, Lewis J. Notch ligands with contrasting functions: Jagged1 and Delta1 in the mouse inner ear. Development 2006; 133(7): p. 1277-86; PMID:16495313; http://dx.doi.org/10.1242/dev.02284
   PubMed Web of Science ®Google Scholar
• Kim SS, Harford JB, Pirollo KF, Chang EH. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: the promise of nanomedicine. Biochem Biophys Res Commun 2015; http://dx.doi.org/10.1016/j.bbrc.2015.06.137
   Web of Science ®Google Scholar
• Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, van der Meer AJ, Patick AK, Chen A, Zhou Y, et al., Treatment of HCV infection by targeting microRNA. N Engl J Med 2013; 368(18): p. 1685-94; PMID:23534542; http://dx.doi.org/10.1056/NEJMoa1209026
   PubMed Web of Science ®Google Scholar
• Reid G, Pel ME, Kirschner MB, Cheng YY, Mugridge N, Weiss J, Williams M, Wright C, Edelman JJ, Vallely MP, et al., Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma. Ann Oncol 2013; 24(12): p. 3128-35; PMID:24148817; http://dx.doi.org/10.1093/annonc/mdt412
   PubMed Web of Science ®Google Scholar
• MacDiarmid JA, Mugridge NB, Weiss JC, Phillips L, Burn AL, Paulin RP, Haasdyk JE, Dickson KA, Brahmbhatt VN, Pattison ST, et al., Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics. Cancer Cell 2007; 11(5): p. 431-45; PMID:17482133; http://dx.doi.org/10.1016/j.ccr.2007.03.012
   PubMed Web of Science ®Google Scholar
• MacDiarmid JA, Amaro-Mugridge NB, Madrid-Weiss J, Sedliarou I, Wetzel S, Kochar K, Brahmbhatt VN, Phillips L, Pattison ST, Petti C, et al., Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug. Nat Biotechnol 2009; 27(7): p. 643-51; PMID:19561595; http://dx.doi.org/10.1038/nbt.1547
   PubMed Web of Science ®Google Scholar
• Jensen SA, Day ES, Ko CH, Hurley LA, Luciano JP, Kouri FM, Merkel TJ, Luthi AJ, Patel PC, Cutler JI, et al., Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Sci Transl Med 2013; 5(209): p. 209ra152; PMID:24174328; http://dx.doi.org/10.1126/scitranslmed.3006839
   PubMed Web of Science ®Google Scholar
• Tivnan A, Orr WS, Gubala V, Nooney R, Williams DE, McDonagh C, Prenter S, Harvey H, Domingo-Fernández R, Bray IM, et al., Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles. PLoS One 2012; 7(5): p. e38129; PMID:22662276; http://dx.doi.org/10.1371/journal.pone.0038129
   PubMed Web of Science ®Google Scholar
• Chiou GY, Cherng JY, Hsu HS, Wang ML, Tsai CM, Lu KH, Chien Y, Hung SC, Chen YW, Wong CI, et al., Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma. J Control Release 2012; 159(2): p. 240-50; PMID:22285547; http://dx.doi.org/10.1016/j.jconrel.2012.01.014
   PubMed Web of Science ®Google Scholar
• Muthiah M, Islam MA, Lee HJ, Moon MJ, Cho CS, Park IK. MicroRNA delivery with osmotic polysorbitol-based transporter suppresses breast cancer cell proliferation. Int J Biol Macromol 2015; 72: p. 1237-43; PMID:25450545; http://dx.doi.org/10.1016/j.ijbiomac.2014.10.041
   PubMed Web of Science ®Google Scholar
• Qureshi AT, Doyle A, Chen C, Coulon D, Dasa V, Del Piero F, Levi B, Monroe WT, Gimble JM, Hayes DJ. Photoactivated miR-148b-nanoparticle conjugates improve closure of critical size mouse calvarial defects. Acta Biomater 2015; 12: p. 166-73; PMID:25462528; http://dx.doi.org/10.1016/j.actbio.2014.10.010
   PubMed Web of Science ®Google Scholar
• Chen Y, Gao DY, Huang L. In vivo delivery of miRNAs for cancer therapy: challenges and strategies. Adv Drug Deliv Rev 2015; 81: p. 128-41; PMID:24859533; http://dx.doi.org/10.1016/j.addr.2014.05.009
   PubMed Web of Science ®Google Scholar
• Wang H, Jiang Y, Peng H, Chen Y, Zhu P, Huang Y. Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors. Adv Drug Deliv Rev 2015; 81: p. 142-60; PMID:25450259; http://dx.doi.org/10.1016/j.addr.2014.10.031
   PubMed Web of Science ®Google Scholar
• Auffinger B, Tobias AL, Han Y, Lee G, Guo D, Dey M, Lesniak MS, Ahmed AU, Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy. Cell Death Differ 2014; 21(7): p. 1119-31; PMID:24608791; http://dx.doi.org/10.1038/cdd.2014.31
   PubMed Web of Science ®Google Scholar